InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AXS | IPO - AXS Group Limited | 28/03/19 | 52 | 24K | |||
|
|||||||
AXS | Pushed out again | 17/02/19 | 1 | 1.2K | |||
|
See All Discussions